You are viewing: France Pharmaceutical Manufacturing Equipment Market analysis

The France Pharmaceutical Manufacturing Equipment Market was valued at $919.8 Million in 2026 and projected to reach to $1247.7 Million by 2031, representing a compound annual growth rate of 5.2%. France's pharmaceutical manufacturing equipment market is poised for steady growth through 2031, supported by the country's established position as a European pharmaceutical manufacturing center.

France Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • France maintains a strategic position within Europe's pharmaceutical sector, driven by robust regulatory frameworks, advanced manufacturing capabilities, and significant investment in biopharmaceutical production infrastructure.
  • The market in France reflects steady demand for precision equipment, automation solutions, and quality control systems essential for modern drug manufacturing. Growth in France's pharmaceutical manufacturing equipment market is underpinned by the country's commitment to pharmaceutical innovation, increasing production capacity for specialty drugs, and compliance with stringent European Union regulations.
  • France's established pharmaceutical industry, supported by major manufacturing hubs and research institutions, continues to drive equipment modernization and technological upgrades.
  • Between 2026 and 2031, France is expected to see accelerated adoption of advanced manufacturing technologies, including continuous processing systems and integrated automation platforms, positioning the country as a key market within the European pharmaceutical equipment landscape..

Key Market Statistics

  • CAGR (2026-2031) 5.2% CAGR
  • Market Size, 2026 ~USD 919.8 Million
  • Forecast, 2031 ~USD 1247.7 Million
  • Country France

France Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation Growth :

France's pharmaceutical manufacturing equipment market is valued at USD 919.8 million in 2026 and is projected to reach USD 1,247.7 million by 2031, demonstrating steady expansion in the country's manufacturing infrastructure.

Consistent CAGR Performance :

The French market is growing at a CAGR of 5.2% from 2026 to 2031, slightly below the global average of 6.2%, reflecting a mature but stable pharmaceutical manufacturing sector with sustainable demand.

Regulatory Excellence & Compliance :

France benefits from stringent EU regulatory frameworks and GMP standards that drive continuous investment in advanced manufacturing equipment, positioning the country as a quality-focused pharmaceutical hub.

Biopharmaceutical Investment Hub :

Significant government and private sector investment in biopharmaceutical production capabilities is accelerating demand for specialized manufacturing equipment, particularly in biologics and personalized medicine sectors.

France Pharmaceutical Manufacturing Equipment Market Dynamics

  • The market benefits from strong regulatory compliance requirements, substantial R&D investments, and the presence of major pharmaceutical manufacturers.
  • Increasing demand for advanced manufacturing technologies, including automation and continuous processing systems, will drive equipment upgrades across French facilities. The shift toward biopharmaceutical production and personalized medicine is creating new opportunities for specialized equipment suppliers.
  • Additionally, France's commitment to pharmaceutical sovereignty and domestic production capacity expansion will sustain capital investments in manufacturing infrastructure.
  • However, growth remains moderate compared to global rates, reflecting market maturity and competitive pressures from other European nations..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • France's pharmaceutical manufacturing equipment market will grow from USD 919.8 million (2026) to USD 1,247.7 million (2031) at a 5.2% CAGR.
    • France's strong regulatory environment and established pharmaceutical infrastructure support sustained demand for advanced manufacturing equipment.
    • Automation and continuous processing technologies are driving modernization investments across France's pharmaceutical manufacturing sector.
    • France's position within the EU pharmaceutical supply chain ensures consistent equipment demand through 2031.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    France Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Equipment Manufacturers & Suppliers : Manufacturers of pharmaceutical production equipment need France-specific market data to identify growth opportunities, benchmark competitive positioning, and develop localized sales strategies for this established European market.
    • Pharmaceutical & Biotech Companies : French and international pharmaceutical firms operating in France require detailed market insights to plan capital expenditures, evaluate equipment upgrades, and align manufacturing investments with market growth trends.
    • Investment & Private Equity Firms : Investors evaluating opportunities in France's pharmaceutical manufacturing sector need comprehensive market data to assess growth potential, identify acquisition targets, and make informed investment decisions.
    • Regulatory & Compliance Consultants : Consultants advising pharmaceutical manufacturers on French regulatory compliance and GMP standards require market-specific insights to guide equipment selection and manufacturing infrastructure recommendations.
    • Market Research & Strategy Teams : Corporate strategy and business development teams need France-focused market intelligence to support competitive analysis, market entry planning, and long-term strategic positioning in the European pharmaceutical sector.

    Key Companies in the France Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for France's pharmaceutical manufacturing equipment market with detailed projections through 2031, enabling accurate budgeting and investment planning specific to the French market.
    • Competitive Landscape Intelligence : Understand France's unique competitive dynamics, regulatory environment, and key market players operating within the country's pharmaceutical manufacturing sector to identify partnership and expansion opportunities.
    • Regulatory & Compliance Insights : Gain detailed knowledge of France's stringent EU regulatory requirements and GMP standards that influence equipment specifications, purchasing decisions, and compliance investments for manufacturers.
    • Biopharmaceutical Growth Opportunities : Identify emerging demand drivers in France's biopharmaceutical and personalized medicine sectors, including specific equipment categories and technology trends shaping future procurement strategies.
    • Strategic Market Entry & Expansion : Leverage France-specific market intelligence to develop targeted go-to-market strategies, identify high-potential customer segments, and optimize resource allocation for market penetration in this mature European economy.

    Frequently asked questions

    What is the current size of France's pharmaceutical manufacturing equipment market?

    France's pharmaceutical manufacturing equipment market is valued at USD 919.8 million in 2026.

    What is the projected market size for France by 2031?

    France's pharmaceutical manufacturing equipment market is projected to reach USD 1,247.7 million by 2031.

    What is the CAGR for France's pharmaceutical manufacturing equipment market?

    France's pharmaceutical manufacturing equipment market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2031.

    What factors are driving growth in France's pharmaceutical manufacturing equipment market?

    Growth in France is driven by regulatory compliance requirements, biopharmaceutical production expansion, automation adoption, and modernization of existing manufacturing facilities.

    How does France's market compare to the broader European pharmaceutical equipment sector?

    France represents a significant segment of Europe's pharmaceutical manufacturing equipment market, supported by its established industry base, regulatory expertise, and strategic manufacturing capabilities.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status